Opdivo 40 mg/4 ml
Opdivo 40 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 65660. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 November 2015 and the authorisation is valid without a time limit. ATC code L01FF01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 65660 |
|---|---|
| Name | Opdivo 40 mg/4 ml |
| Full name | Opdivo 40 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Bristol-Myers Squibb SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FF01 |
| First authorisation | 30 November 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Opdivo 40 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 30 November 2015 |
| 2 | Opdivo 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 30 November 2015 |
| 3 | Opdivo 240 mg/24 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 25 January 2018 |
| 4 | Opdivo 120 mg/12 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 27 October 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FF01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FF01 | 07.16.1. | A |
| 3 | 1 | Durchstechflasche(n) | L01FF01 | 07.16.1. | A |
| 4 | 1 | Durchstechflasche(n) | L01FF01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Opdivo 40 mg/4 ml authorised in Switzerland?
Yes. Opdivo 40 mg/4 ml is authorised by Swissmedic under authorisation number 65660, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Opdivo 40 mg/4 ml have?
Opdivo 40 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Opdivo 40 mg/4 ml?
The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.